Le nostre storie Le nostre storie 10.5 million investments for the research in the biomedical sector January 2, 2017 shareAn investment of almost 15 million euros to develop the world’s first linear proton accelerator in the upcoming years, which will be produced by Newco Linear Beam srl, spin-off from Itel Investments of about 10 and [...]

.fusion-button.button-1 .fusion-button-text{color:#ffffff;text-transform:uppercase;}.fusion-button.button-1{border-color:#ffffff;border-width:1px 1px 1px 1px;border-radius:0px 0px 0px 0px;background:rgba(0,51,122,0);background-image:linear-gradient(180deg,rgba(0,51,122,0) 0%,rgba(0,41,99,0) 100%);}.fusion-button.button-1 i,.fusion-button.button-1:hover .fusion-button-text,.fusion-button.button-1:hover i,.fusion-button.button-1:focus .fusion-button-text,.fusion-button.button-1:focus i,.fusion-button.button-1:active .fusion-button-text,.fusion-button.button-1:active i{color:#ffffff;}.fusion-button.button-1:hover,.fusion-button.button-1:active,.fusion-button.button-1:focus{border-color:#ffffff;border-width:1px 1px 1px 1px;background:rgba(0,0,0,0.4);}.fusion-button.button-1 .fusion-button-icon-divider,.fusion-button.button-1:hover .fusion-button-icon-divider,.fusion-button.button-1:active .fusion-button-icon-divider,.fusion-button.button-1:focus .fusion-button-icon-divider{border-color:#ffffff;}Le nostre storie Le nostre storie 10.5 million investments for the research in the biomedical sector January 2, 2017 share.fusion-sharing-box-1 h4{margin-bottom:0 !important;}.fusion-sharing-box-1{flex-direction:row !important;}@media only screen and (max-width:1024px){.fusion-sharing-box-1 h4{margin-right:0.5em !important;margin-bottom:0 !important;}.sharingbox-shortcode-icon-wrapper-1{width:auto !important;justify-content:flex-end !important;}.fusion-sharing-box-1{align-items:center [...]

.fusion-button.button-1 .fusion-button-text{color:#ffffff;text-transform:uppercase;}.fusion-button.button-1{border-color:#ffffff;border-width:1px 1px 1px 1px;border-radius:0px 0px 0px 0px;background:rgba(0,51,122,0);background-image:linear-gradient(180deg,rgba(0,51,122,0) 0%,rgba(0,41,99,0) 100%);}.fusion-button.button-1 i,.fusion-button.button-1:hover .fusion-button-text,.fusion-button.button-1:hover i,.fusion-button.button-1:focus .fusion-button-text,.fusion-button.button-1:focus i,.fusion-button.button-1:active .fusion-button-text,.fusion-button.button-1:active i{color:#ffffff;}.fusion-button.button-1:hover,.fusion-button.button-1:active,.fusion-button.button-1:focus{border-color:#ffffff;border-width:1px 1px 1px 1px;background:rgba(0,0,0,0.4);}.fusion-button.button-1 .fusion-button-icon-divider,.fusion-button.button-1:hover .fusion-button-icon-divider,.fusion-button.button-1:active .fusion-button-icon-divider,.fusion-button.button-1:focus .fusion-button-icon-divider{border-color:#ffffff;}Le nostre storie Le nostre storie 10.5 million investments for the research in the biomedical sector January 2, 2017 share.fusion-sharing-box-1 h4{margin-bottom:0 !important;}.fusion-sharing-box-1{flex-direction:row !important;}@media only screen and (max-width:1024px){.fusion-sharing-box-1 h4{margin-right:0.5em !important;margin-bottom:0 !important;}.sharingbox-shortcode-icon-wrapper-1{width:auto !important;justify-content:flex-end !important;}.fusion-sharing-box-1{align-items:center [...]

.fusion-button.button-1 .fusion-button-text, .fusion-button.button-1 i {color:#ffffff;}.fusion-button.button-1 .fusion-button-icon-divider{border-color:#ffffff;}.fusion-button.button-1:hover .fusion-button-text, .fusion-button.button-1:hover i,.fusion-button.button-1:focus .fusion-button-text, .fusion-button.button-1:focus i,.fusion-button.button-1:active .fusion-button-text, .fusion-button.button-1:active{color:#ffffff;}.fusion-button.button-1:hover .fusion-button-icon-divider, .fusion-button.button-1:hover .fusion-button-icon-divider, .fusion-button.button-1:active .fusion-button-icon-divider{border-color:#ffffff;}.fusion-button.button-1:hover, .fusion-button.button-1:focus, .fusion-button.button-1:active{border-color:#ffffff;border-width:1px;}.fusion-button.button-1 {border-color:#ffffff;border-width:1px;border-radius:0px;}.fusion-button.button-1{background: rgba(0,51,122,0); background-image: -webkit-gradient( linear, left bottom, left top, from( rgba(0,41,99,0) ), to( rgba(0,51,122,0) ) ); background-image: -webkit-linear-gradient( bottom, rgba(0,41,99,0), rgba(0,51,122,0) ); background-image: -moz-linear-gradient( bottom, rgba(0,41,99,0), rgba(0,51,122,0) ); background-image: -o-linear-gradient( bottom, rgba(0,41,99,0), rgba(0,51,122,0) ); [...]

Le nostre storie Le nostre storie Arabs take lessons from Itel’s nuclear medicine November 6, 2016 shareA delegation from the University of Jeddah came to visit “Ospedali Riuniti” of Foggia where, thanks to the recent agreement deal with Itel, was equipped with a Pet / Tac that allows the precise identification of neuroendocrine tumors On [...]

.fusion-button.button-2 .fusion-button-text{color:#ffffff;text-transform:uppercase;}.fusion-button.button-2{border-color:#ffffff;border-width:1px 1px 1px 1px;border-radius:0px 0px 0px 0px;background:rgba(0,51,122,0);background-image:linear-gradient(180deg,rgba(0,51,122,0) 0%,rgba(0,41,99,0) 100%);}.fusion-button.button-2 i,.fusion-button.button-2:hover .fusion-button-text,.fusion-button.button-2:hover i,.fusion-button.button-2:focus .fusion-button-text,.fusion-button.button-2:focus i,.fusion-button.button-2:active .fusion-button-text,.fusion-button.button-2:active i{color:#ffffff;}.fusion-button.button-2:hover,.fusion-button.button-2:active,.fusion-button.button-2:focus{border-color:#ffffff;border-width:1px 1px 1px 1px;background:rgba(0,0,0,0.4);}.fusion-button.button-2 .fusion-button-icon-divider,.fusion-button.button-2:hover .fusion-button-icon-divider,.fusion-button.button-2:active .fusion-button-icon-divider,.fusion-button.button-2:focus .fusion-button-icon-divider{border-color:#ffffff;}Le nostre storie Le nostre storie Arabs take lessons from Itel’s nuclear medicine November 6, 2016 share.fusion-sharing-box-2 h4{margin-bottom:0 !important;}.fusion-sharing-box-2{flex-direction:row !important;}@media only screen and (max-width:1024px){.fusion-sharing-box-2 h4{margin-right:0.5em !important;margin-bottom:0 !important;}.sharingbox-shortcode-icon-wrapper-2{width:auto !important;justify-content:flex-end !important;}.fusion-sharing-box-2{align-items:center !important;} }@media only [...]

.fusion-button.button-2 .fusion-button-text, .fusion-button.button-2 i {color:#ffffff;}.fusion-button.button-2 .fusion-button-icon-divider{border-color:#ffffff;}.fusion-button.button-2:hover .fusion-button-text, .fusion-button.button-2:hover i,.fusion-button.button-2:focus .fusion-button-text, .fusion-button.button-2:focus i,.fusion-button.button-2:active .fusion-button-text, .fusion-button.button-2:active{color:#ffffff;}.fusion-button.button-2:hover .fusion-button-icon-divider, .fusion-button.button-2:hover .fusion-button-icon-divider, .fusion-button.button-2:active .fusion-button-icon-divider{border-color:#ffffff;}.fusion-button.button-2:hover, .fusion-button.button-2:focus, .fusion-button.button-2:active{border-color:#ffffff;border-width:1px;}.fusion-button.button-2 {border-color:#ffffff;border-width:1px;border-radius:0px;}.fusion-button.button-2{background: rgba(0,51,122,0); background-image: -webkit-gradient( linear, left bottom, left top, from( rgba(0,41,99,0) ), to( rgba(0,51,122,0) ) ); background-image: -webkit-linear-gradient( bottom, rgba(0,41,99,0), rgba(0,51,122,0) ); background-image: -moz-linear-gradient( bottom, rgba(0,41,99,0), rgba(0,51,122,0) ); background-image: -o-linear-gradient( bottom, rgba(0,41,99,0), rgba(0,51,122,0) ); [...]

Le nostre storie Le nostre storie Second production line and four new molecules for Itelpharma October 31, 2016 shareThey will provide to diagnose neurogenerative diseases. President Diaferia: “It gives me joy to see how many professional talents are growing in and with our company” In 2015 Itelpharma division has generated a turnover of 2.8 million [...]

.fusion-button.button-3 .fusion-button-text{color:#ffffff;text-transform:uppercase;}.fusion-button.button-3{border-color:#ffffff;border-width:1px 1px 1px 1px;border-radius:0px 0px 0px 0px;background:rgba(0,51,122,0);background-image:linear-gradient(180deg,rgba(0,51,122,0) 0%,rgba(0,41,99,0) 100%);}.fusion-button.button-3 i,.fusion-button.button-3:hover .fusion-button-text,.fusion-button.button-3:hover i,.fusion-button.button-3:focus .fusion-button-text,.fusion-button.button-3:focus i,.fusion-button.button-3:active .fusion-button-text,.fusion-button.button-3:active i{color:#ffffff;}.fusion-button.button-3:hover,.fusion-button.button-3:active,.fusion-button.button-3:focus{border-color:#ffffff;border-width:1px 1px 1px 1px;background:rgba(0,0,0,0.4);}.fusion-button.button-3 .fusion-button-icon-divider,.fusion-button.button-3:hover .fusion-button-icon-divider,.fusion-button.button-3:active .fusion-button-icon-divider,.fusion-button.button-3:focus .fusion-button-icon-divider{border-color:#ffffff;}Le nostre storie Le nostre storie Second production line and four new molecules for Itelpharma October 31, 2016 share.fusion-sharing-box-3 h4{margin-bottom:0 !important;}.fusion-sharing-box-3{flex-direction:row !important;}@media only screen and (max-width:1024px){.fusion-sharing-box-3 h4{margin-right:0.5em !important;margin-bottom:0 !important;}.sharingbox-shortcode-icon-wrapper-3{width:auto !important;justify-content:flex-end !important;}.fusion-sharing-box-3{align-items:center !important;} [...]

.fusion-button.button-3 .fusion-button-text, .fusion-button.button-3 i {color:#ffffff;}.fusion-button.button-3 .fusion-button-icon-divider{border-color:#ffffff;}.fusion-button.button-3:hover .fusion-button-text, .fusion-button.button-3:hover i,.fusion-button.button-3:focus .fusion-button-text, .fusion-button.button-3:focus i,.fusion-button.button-3:active .fusion-button-text, .fusion-button.button-3:active{color:#ffffff;}.fusion-button.button-3:hover .fusion-button-icon-divider, .fusion-button.button-3:hover .fusion-button-icon-divider, .fusion-button.button-3:active .fusion-button-icon-divider{border-color:#ffffff;}.fusion-button.button-3:hover, .fusion-button.button-3:focus, .fusion-button.button-3:active{border-color:#ffffff;border-width:1px;}.fusion-button.button-3 {border-color:#ffffff;border-width:1px;border-radius:0px;}.fusion-button.button-3{background: rgba(0,51,122,0); background-image: -webkit-gradient( linear, left bottom, left top, from( rgba(0,41,99,0) ), to( rgba(0,51,122,0) ) ); background-image: -webkit-linear-gradient( bottom, rgba(0,41,99,0), rgba(0,51,122,0) ); background-image: -moz-linear-gradient( bottom, rgba(0,41,99,0), rgba(0,51,122,0) ); background-image: -o-linear-gradient( bottom, rgba(0,41,99,0), rgba(0,51,122,0) ); [...]